Yvonne Chekaluk, M.S., Molecular and Cellular Biology - Memorial Sloan Kettering Cancer Center - Clinical Genetic's Technologist

Yvonne Chekaluk

M.S., Molecular and Cellular Biology

Memorial Sloan Kettering Cancer Center

Clinical Genetic's Technologist

NY, NY | United States

Main Specialties: Other

Additional Specialties: Next Generation Sequencing

Yvonne Chekaluk, M.S., Molecular and Cellular Biology - Memorial Sloan Kettering Cancer Center - Clinical Genetic's Technologist

Yvonne Chekaluk

M.S., Molecular and Cellular Biology

Introduction

Primary Affiliation: Memorial Sloan Kettering Cancer Center - NY, NY , United States

Specialties:

Additional Specialties:

Research Interests:


View Yvonne Chekaluk’s Resume / CV

Publications

11Publications

293Reads

-Profile Views

189PubMed Central Citations

BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.

PLoS One 2015 1;10(4):e0119224. Epub 2015 Apr 1.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0119224PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382119PMC
December 2015
4 Reads
3 Citations
3.234 Impact Factor

Targeted deletion of Tsc1 causes fatal cardiomyocyte hyperplasia independently of afterload.

Cardiovasc Pathol 2015 Mar-Apr;24(2):80-93. Epub 2014 Nov 7.

Pulmonary, Critical Care & Sleep Division, Department of Medicine, Tupper Research Institute, Tufts Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carpath.2014.10.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344870PMC
November 2015
50 Reads
1 Citation
2.340 Impact Factor

A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.

Hum Mol Genet 2015 Apr 28;24(7):1836-42. Epub 2014 Nov 28.

Division of Pulmonary Medicine and of Genetics, Brigham and Women's Hospital, Boston, MA, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddu597DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355019PMC
April 2015
37 Reads
12 Citations
6.393 Impact Factor

Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.

Clin Cancer Res 2014 Apr 31;20(7):1873-83. Epub 2014 Jan 31.

Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0759DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975677PMC
April 2014
32 Reads
13 Citations
8.722 Impact Factor

Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex.

Hum Mol Genet 2014 Apr 23;23(8):2023-9. Epub 2013 Nov 23.

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/hmg/article-lookup/doi/10.1093/hmg/
Publisher Site
http://dx.doi.org/10.1093/hmg/ddt597DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959815PMC
April 2014
7 Reads
24 Citations
6.393 Impact Factor

Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.

PLoS One 2013 4;8(4):e60927. Epub 2013 Apr 4.

Division of Translational Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0060927PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617176PMC
November 2013
17 Reads
10 Citations
3.234 Impact Factor

TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.

J Pathol 2013 May 21;230(1):17-27. Epub 2013 Mar 21.

Division of Translational Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4176DOI Listing
May 2013
23 Reads
13 Citations
7.430 Impact Factor

Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex.

Proc Natl Acad Sci U S A 2011 Nov 24;108(45):E1070-9. Epub 2011 Oct 24.

Translational Medicine Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1106454108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214999PMC
November 2011
7 Reads
61 Citations
9.810 Impact Factor